GSK Capital plc

03 January 2013

£600,000,000 3.375% Bonds due 2027
£800,000,000 4.25% Bonds due 2045

We have been appointed as trustee for these two new bonds, issued under GlaxoSmithKline’s EMTN Programme.
Back to top